BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10967440)

  • 1. Compressed xanthan and karaya gum matrices: hydration, erosion and drug release mechanisms.
    Munday DL; Cox PJ
    Int J Pharm; 2000 Aug; 203(1-2):179-92. PubMed ID: 10967440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between swelling, erosion and drug release in hydrophillic natural gum mini-matrix formulations.
    Sujja-areevath J; Munday DL; Cox PJ; Khan KA
    Eur J Pharm Sci; 1998 Jul; 6(3):207-17. PubMed ID: 9795062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthan gum to tailor drug release of sustained-release ethylcellulose mini-matrices prepared via hot-melt extrusion: in vitro and in vivo evaluation.
    Verhoeven E; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2006 Jul; 63(3):320-30. PubMed ID: 16517135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation variables affecting drug release from xanthan gum matrices at laboratory scale and pilot scale.
    Billa N; Yuen KH
    AAPS PharmSciTech; 2000 Oct; 1(4):E30. PubMed ID: 14727895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of calcium salts into xanthan gum matrices: hydration, erosion and drug release characteristics.
    Groves E; Chaw CS
    Drug Dev Ind Pharm; 2015; 41(10):1608-16. PubMed ID: 25371230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
    Varshosaz J; Tavakoli N; Kheirolahi F
    AAPS PharmSciTech; 2006 Mar; 7(1):E24. PubMed ID: 16584155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of selected polysaccharide excipients in buccoadhesive tablets for sustained release of nicotine.
    Park CR; Munday DL
    Drug Dev Ind Pharm; 2004 Jul; 30(6):609-17. PubMed ID: 15285334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compaction, compression and drug release properties of diclofenac sodium and ibuprofen pellets comprising xanthan gum as a sustained release agent.
    Santos H; Veiga F; Pina ME; Sousa JJ
    Int J Pharm; 2005 May; 295(1-2):15-27. PubMed ID: 15898143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca-carboxymethyl xanthan gum mini-matrices: Swelling, erosion and their impact on drug release mechanism.
    Maity S; Sa B
    Int J Biol Macromol; 2014 Jul; 68():78-85. PubMed ID: 24768968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral controlled release formulation for highly water-soluble drugs: drug--sodium alginate--xanthan gum--zinc acetate matrix.
    Zeng WM
    Drug Dev Ind Pharm; 2004 May; 30(5):491-5. PubMed ID: 15244084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline.
    Vendruscolo CW; Andreazza IF; Ganter JL; Ferrero C; Bresolin TM
    Int J Pharm; 2005 May; 296(1-2):1-11. PubMed ID: 15885450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of natural gum-based extended release matrix tablets of two model drugs of different water solubilities by direct compression.
    Ofori-Kwakye K; Mfoafo KA; Kipo SL; Kuntworbe N; Boakye-Gyasi ME
    Saudi Pharm J; 2016 Jan; 24(1):82-91. PubMed ID: 26903772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of hydrophilic swellable polymers as carriers for sustained drug delivery from matrices and three layer tablet systems.
    Vlachou M; Naseef H; Efentakis M
    Curr Drug Deliv; 2010 Oct; 7(4):334-42. PubMed ID: 20695845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and characterization of neurodurable gellan-xanthan pH-responsive hydrogels for controlled drug delivery.
    Ramburrun P; Kumar P; Choonara YE; du Toit LC; Pillay V
    Expert Opin Drug Deliv; 2017 Mar; 14(3):291-306. PubMed ID: 27892726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
    Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
    Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural gum as mucoadhesive controlled release carriers: evaluation of cefpodoxime proxetil by D-optimal design technique.
    Patil SH; Talele GS
    Drug Deliv; 2014 Mar; 21(2):118-29. PubMed ID: 24032629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural gum-type biopolymers as potential modified nonpolar drug release systems.
    Salamanca CH; Yarce CJ; Moreno RA; Prieto V; Recalde J
    Carbohydr Polym; 2018 Jun; 189():31-38. PubMed ID: 29580414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, development and in-vitro evaluation of metoprolol tartrate tablets containing xanthan-tragacanth.
    Rasul A; Iqbal M; Murtaza G; Waqas MK; Hanif M; Khan SA; Bhatti NS
    Acta Pol Pharm; 2010; 67(5):517-22. PubMed ID: 20873420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.